Conclusion
Competency
in the performance of cardiovascular ultrasound examinations requires
maintenance of skills in each area of practice. Each sonographer should meet
the applicable procedure volume requirements and continuing medical education
requirements set forth in the ICAEL standards. As of April, 2002, the ICAEL
procedure volume standards require the performance of 300 resting transthoracic
echocardiograms per year and 100 stress echocardiograms per year.
Sonographers
must fulfill such continuing medical education requirements as may be required
by the applicable credentialing organization. Those sonographers who provide
services in accredited laboratories also should meet any applicable ICAEL
continuing medical education requirements.
Sonographers
must adhere to the scope of practice for diagnostic ultrasound professionals,
and the code of ethics and must in peer review and quality assurance activities
as required by the institution that operates the laboratory and by ICAEL
standards if applicable.
Three-dimensional
echocardiography is a safe, noninvasive imaging modality that is complementary
and supplementary to 2D imaging and can be used to assess cardiovascular
function and anatomy in various clinical settings. At present, available
evidence suggests that 3D echocardiography provides improved accuracy and
reproducibility over 2D methods for LV volume and function calculation and the
derivation of mitral valve area in patients with mitral stenosis. Further
technological improvements and additional clinical studies will broaden the
list of appropriate applications for this exciting new ultrasound modality.
The ASE
supports and encourages an expanded role of the credentialed cardiac
sonographer in the selection of patients and the administration of contrast agents
for echocardiography. Such responsibilities require a thorough understanding of
micro bubble characteristics and interaction with cardiac ultrasound and the
indications (and contraindications) for contrast agent injections. The cardiac
sonographer must comply with established policies and procedures, as outlined
in specific written protocols developed by the echocardiography laboratory
director. When responsible for obtaining IV access, this person must have
appropriate training with certification. The injection or infusion of agents
ideally should be done by a physician or registered nurse following proper
techniques. The use of contrast agents should be reserved for accredited or, at
least, Level II echocardiography laboratories in which direct physician
supervision and registered nurse support are available.
Echocardiography
plays an exciting and evolving role in the care of patient with CRT, from quantifying
improvements in ventricular function and MR to optimizing the device after
implantation. Although a great deal of work has been done to quantify
mechanical dyssynchrony in hopes of refining patient selection and guiding lead
placement, this is a complex and challenging field with future work needed and
several promising studies ongoing. Technologic improvements in
echocardiographic data acquisition and analysis as well as advances in our
understanding of the pathophysiology of dyssynchrony and CRT have great
potential to impact future clinical practice and improve patient outcome. The
Dyssynchrony Writing Group is indebted to Ashley Prather and the American
Society of Echocardiography staff for administrative and organizational
assistance.
No comments:
Post a Comment